Jay Magaziner

TL;DR: An annual infusion of zoledronic acid within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate of new clinical fractures and with improved survival.

TL;DR: Functional disability following hip fracture is significant, patterns of recovery differ by area of function, and there appears to be an orderly sequence by which areas of function reach their maximal levels.

TL;DR: Hip fracture has a substantial impact on older peoples’ medium- to longer-term abilities, function, quality of life and accommodation and future studies should measure impact on life participation and determine the proportion of people that regain their pre-fracture level of functioning to investigate strategies for improving these important outcomes.

TL;DR: There is an immediate increase in mortality following a hip fracture in medically ill and functionally impaired patients, whereas among those with no comorbidities and few impairments, there is a gradual increase inortality that continues for 5 years postfracture.

TL;DR: Liberal blood transfusion did not affect mortality compared with a restrictive transfusion strategy in a high-risk group of elderly patients with underlying cardiovascular disease or risk factors, and these findings do not support hypotheses that blood transfusions leads to long-term immunosuppression that is severe enough to affect long- term mortality rate by more than 20-25% or cause of death.